These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25703896)

  • 1. Legal cognitive requirements impact on pharmacy practice and patient outcomes.
    Svensberg K; Björnsdottir I; Kälvemark Sporrong S
    Res Social Adm Pharm; 2015; 11(4):590-1. PubMed ID: 25703896
    [No Abstract]   [Full Text] [Related]  

  • 2. Warranties of a compounding pharmacist.
    Brushwood DB; Smith WT
    Am J Health Syst Pharm; 2009 Mar; 66(5):495-8. PubMed ID: 19233998
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacists' liability: what my pharmacy law professor did not cover.
    Rizo M; Seamon M
    Int J Pharm Compd; 2013; 17(4):290-3. PubMed ID: 24261143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compounding pharmacies: before and after an inspection.
    Kulkarni D; Ricketts S
    Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The art, science, and practice of pharmacy compounding.
    McDonough RP; Allen LV; Wettergreen S
    J Am Pharm Assoc (2003); 2013; 53(1):8-12. PubMed ID: 23636149
    [No Abstract]   [Full Text] [Related]  

  • 7. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.
    Akers MJ
    Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the 2015 APhA House of Delegates.
    J Am Pharm Assoc (2003); 2015; 55(4):364-75. PubMed ID: 26161480
    [No Abstract]   [Full Text] [Related]  

  • 9. Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies.
    Pritchett J; McCrory G; Kraemer C; Jensen B; Allen LV
    Int J Pharm Compd; 2018; 22(1):7-16. PubMed ID: 29385381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compounding practices in Iran.
    Goodarzi N; Niknam S; Akbarzadeh T; Gholami K
    Int J Pharm Compd; 2014; 18(2):112-6. PubMed ID: 24881113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' Patient Care Process: State "Scope of Practice" Priorities for Action.
    Adams AJ; Weaver KK
    Ann Pharmacother; 2021 Apr; 55(4):549-555. PubMed ID: 32787618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Academy of Compounding Pharmacists Legislative/Regulatory Update.
    Rice B
    Int J Pharm Compd; 2017; 21(3):212-213. PubMed ID: 28557782
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction to Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of the APhA and APhA-ASP Houses of Delegates.
    Bzowyckyj A; Oestreich J; Kirk LM
    J Am Pharm Assoc (2003); 2015; 55(4):340, 342-4, 346-7. PubMed ID: 26161477
    [No Abstract]   [Full Text] [Related]  

  • 15. The U.S. Food and Drug Administration responds to the International Academy of Compounding Pharmacists' outsourcing letter.
    Int J Pharm Compd; 2014; 18(3):208. PubMed ID: 25306767
    [No Abstract]   [Full Text] [Related]  

  • 16. Compounding pharmacy: old methods finding a new niche.
    Matheny C; Martin CM
    Consult Pharm; 2010 Jun; 25(6):357-63. PubMed ID: 20534406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Academy of Compounding Pharmacists. Legislative/regulatory update. Preserving patient access--compounders on Capitol Hill 2013!
    Miller DG
    Int J Pharm Compd; 2013; 17(4):302-4. PubMed ID: 24261145
    [No Abstract]   [Full Text] [Related]  

  • 18. Why Become Pharmacy Compounding Accreditation Board Accredited?
    Dillon LR
    Int J Pharm Compd; 2016; 20(6):469-474. PubMed ID: 28339385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "Lists": What Do They Mean?
    Voliva J
    Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA, states discuss pharmacy compounding regulatory framework.
    Traynor K
    Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.